Patrick Soon-Shiong

$8.79 B

Ranked #384 in World

About Patrick Soon-Shiong

Renowned transplant surgeon and businessman Patrick Soon-Shiong, born in South Africa to Chinese immigrants, excelled in medicine early, earning his degree at 23. Moving to the U.S., he became a celebrated UCLA transplant surgeon and a pivotal figure in diabetes treatment innovation. His entrepreneurial spirit led to significant pharmaceutical advancements and lucrative sales of his companies, including a $4.6 billion deal with Fresenius and a $3 billion Celgene transaction. Soon-Shiong's recent efforts focus on converging technology and healthcare, highlighted by his push for a universal COVID-19 vaccine and expansion into Africa's vaccine development. Also known for substantial media and technology investments, Soon-Shiong shapes various industry landscapes while based in Los Angeles with his family.

Born

July 29, 1952 in Port Elizabeth, Union of South Africa

Age

73 years

Source Of Wealth

Pharmaceuticals

Industries

Healthcare

Citizenship

United States

Residence

Los Angeles, California

Education

Master of Science, University of British Columbia; Bachelor of Arts/Science, University of Witwatersrand; Medical Doctor, University of Witwatersrand

Spouse

Michele B. Chan

Children

2, including Nika

Patrick Soon-Shiong was born on July 29, 1952, in Port Elizabeth, South Africa. His Chinese immigrant parents, Soon-Shiong and May Soon-Shiong, fled China during World War II. Patrick displayed exceptional academic abilities from an early age and graduated fourth out of 200 students from the University of Witwatersrand with a bachelor's degree in medicine (MBBCh) at the remarkable age of 23. He then completed his medical internship at Johannesburg's General Hospital.

Patrick Soon-Shiong: Family

Patrick Soon-Shiong is married to former actress Michele B. Chan, and they have two children together, including Nika Soon-Shiong. The family resides in Los Angeles.

Patrick Soon-Shiong: Career Highlights

Soon-Shiong joined UCLA Medical School in 1983 as a transplant surgeon and made significant contributions to the field of medicine. He performed the first whole-pancreas transplant at UCLA and developed and performed the experimental Type 1 diabetes treatment known as encapsulated-human-islet transplant. In 2009, he returned to UCLA as a professor of microbiology, immunology, molecular genetics, and bioengineering, and also served as a visiting professor at Imperial College, London, in 2011.

Patrick Soon-Shiong: Companies

Soon-Shiong has founded and led several successful companies in the healthcare and technology sectors. In 1991, he founded VivoRx Inc., which led to the establishment of APP Pharmaceuticals in 1997. He sold APP Pharmaceuticals to Fresenius SE for $4.6 billion in 2008. Soon-Shiong also founded Abraxis BioScience, the maker of Abraxane, and sold it to Celgene in 2010 for over $3 billion. In 2007, he established NantHealth to provide fiber-optic, cloud-based data infrastructure for healthcare information sharing. He went on to found NantWorks in 2011, converging technology to transform various industries. Other notable companies founded by Soon-Shiong include NantOmics, the Healthcare Transformation Institute (HTI), NantKwest, and ImmunityBio, Inc.

Patrick Soon-Shiong: Major Achievements

Soon-Shiong's major achievements include the development of Abraxane, a chemotherapy drug, and the encapsulated-human-islet transplant for Type 1 diabetes.

He has also made significant contributions to the field of healthcare technology through his companies, such as NantHealth and NantWorks. Soon-Shiong's work has been recognized by numerous awards and honors, including the Ellis Island Medal of Honor and the National Medal of Technology and Innovation.

Patrick Soon-Shiong: Awards & Achievements

Soon-Shiong has received numerous prestigious awards and honors throughout his career. Some of his notable accolades include the Ellis Island Medal of Honor, the National Medal of Technology and Innovation, the Horatio Alger Award, and the Ernst & Young Entrepreneur of the Year Award. He has also been recognized by Forbes magazine as one of the world's billionaires and one of the most influential people in healthcare.

Patrick Soon-Shiong: Personal Life & Legacy

Patrick Soon-Shiong is a renowned transplant surgeon, businessman, and media proprietor who has made significant contributions to the fields of medicine and technology. His entrepreneurial spirit and innovative thinking have led to the development of groundbreaking treatments and companies that have transformed healthcare. Soon-Shiong's legacy will continue to inspire future generations of scientists, entrepreneurs, and innovators.

Patrick Soon-Shiong: Trivia

Here are some interesting facts about Patrick Soon-Shiong:

He is an avid art collector and owns a significant collection of contemporary art.
Soon-Shiong is a philanthropist and has donated millions of dollars to various charitable organizations, including the UCLA Medical School and the Children's Hospital Los Angeles.
He is a licensed pilot and enjoys flying his own plane.
Soon-Shiong is a strong advocate for healthcare reform and has been involved in several initiatives to improve access to healthcare in the United States.
He has received honorary doctorates from several universities, including the University of Witwatersrand, the University of Southern California, and the University of California, Los Angeles.

Wealth History

Timeline

July 29, 1952

Patrick Soon-Shiong is born in Port Elizabeth, South Africa.

1979

Earns a master's degree from the University of British Columbia.

1983

Joins UCLA Medical School as a transplant surgeon.

1984

Becomes a board-certified surgeon in the United States.

1991

Founds VivoRx Inc., leading to the establishment of APP Pharmaceuticals in 1997.

1998

Purchases Fujisawa and uses its revenues to develop Abraxane, a chemotherapy drug.

2007

Establishes NantHealth to provide fiber-optic, cloud-based data infrastructure for healthcare information sharing.

2008

Sells APP Pharmaceuticals to Fresenius SE for $4.6 billion.

2009

Returns to UCLA as a professor of microbiology, immunology, molecular genetics, and bioengineering.

2010

Founds Abraxis BioScience, maker of Abraxane, and sells it to Celgene for over $3 billion.

2010

Co-founds the Healthcare Transformation Institute (HTI) to promote healthcare integration in the United States.

2011

Founds NantWorks, converging technology to transform various industries.

2011

Visiting professor at Imperial College, London.

2013

Launches NantOmics to develop cancer drugs based on protein kinase inhibitors.

2015

Initiates an IPO for NantKwest, representing the highest value biotech IPO in history.

2015

Acquires Cynviloq from Sorrento Therapeutics but does not pursue FDA approval, leading to criticism.

2016

Launches the National Immunotherapy Coalition to encourage collaboration in cancer drug testing.

2017

Meets with former Vice President Joe Biden to discuss ambitious approaches to fighting cancer.

2017

Meets with President-elect Donald Trump to discuss national medical priorities.

2017

Appointed to the Health Information Technology Advisory Committee by House Speaker Paul Ryan.

2018

Acquires the Los Angeles Times and The San Diego Union-Tribune.

2021

Merges NantKwest with ImmunityBio, creating ImmunityBio, Inc.

2021

Announces investment in NantRenewables, a biorenewables company.

2022

Invests in Sienza, a lithium battery company.

2023

Sells the San Diego Union-Tribune to MediaNews Group.

Patrick Soon-Shiong : FAQs

What is Patrick Soon-Shiong's current net worth?

Patrick Soon-Shiong's current net worth is $8.79 billion.

What is Patrick Soon-Shiong's current global rank among billionaires?

Patrick Soon-Shiong holds the 384th position globally among billionaires.

What is Patrick Soon-Shiong's current ranking within the United States?

Patrick Soon-Shiong holds the 151st position in United States.

What was the change in Patrick Soon-Shiong's net worth compared to the previous year?

Patrick Soon-Shiong's net worth increased by 3.39 billion dollars compared to the previous year 2025, when his net worth was 5.40 billion dollars.

What is the recent change in Patrick Soon-Shiong's net worth?

Patrick Soon-Shiong's net worth decreased by 331.38 million dollars recently, a 3.77% decrease, with his net worth standing at 8.79 billion dollars.

What are Patrick Soon-Shiong's main sources of wealth?

Patrick Soon-Shiong's main source of income comes from Pharmaceuticals.

In which industry does Patrick Soon-Shiong primarily operate?

Patrick Soon-Shiong is primarily involved in the Healthcare industry.

What is Patrick Soon-Shiong educational background?

Patrick Soon-Shiong holds a Master of Science from the University of British Columbia, a Bachelor of Arts/Science from the University of Witwatersrand and a Medical Doctor from the University of Witwatersrand.

How old is Patrick Soon-Shiong?

Patrick Soon-Shiong is 73 years old.

How many children does Patrick Soon-Shiong have?

Patrick Soon-Shiong has 2 children.

Who is Patrick Soon-Shiong and what is his contribution to the medical field?

Patrick Soon-Shiong is an American transplant surgeon, businessman, and media proprietor known for performing the first whole-pancreas transplant at UCLA and developing treatments for Type 1 diabetes, including the encapsulated-human-islet transplant.

How has Patrick Soon-Shiong influenced the business and healthcare industries?

Patrick Soon-Shiong has made significant impacts with the creation of revolutionary drugs like Abraxane, founding companies like NantHealth for healthcare information sharing, and launching entities such as NantOmics focused on personalized cancer treatment.

What investments has Patrick Soon-Shiong made, and what media entities did he acquire?

As an investor, Patrick Soon-Shiong has notably invested early in Zoom and other tech startups, acquired Los Angeles Times and The San Diego Union-Tribune, and expanded into renewable energy and lithium battery companies.

What is known about Patrick Soon-Shiong's personal life and family?

Patrick Soon-Shiong is married to former actress Michele B. Chan, has two children including Nika Soon-Shiong, and resides in Los Angeles, where he is also active in the local community and philanthropy.